MedPath
NMPA Approval

Ozagrel Sodium Injection

国药准字H20183406

October 15, 2018

Drug Information

奥扎格雷钠注射液

注射剂

2ml:40mg(按C13H11N2NaO2计)

化学药品

October 15, 2018

Company Information

Applicant Company

北辰科技园区华实道88号

Manufacturing Company

北辰科技园区华实道88号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

奥扎格雷钠注射液 - NMPA 批准文号 | MedPath